Deutsche Bank’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.65M | Buy |
|
|||||
|
2025
Q2 | $2.23M | Sell |
|
|||||
|
2025
Q1 | $1.89M | Sell |
|
|||||
|
2024
Q4 | $3.9M | Sell |
|
|||||
|
2024
Q3 | $7.25M | Buy |
|
|||||
|
2024
Q2 | $5.52M | Buy |
|
|||||
|
2024
Q1 | $7.26M | Buy |
|
|||||
|
2023
Q4 | $154K | Sell |
|
|||||
|
2023
Q3 | $112K | Buy |
|
|||||
|
2023
Q2 | $154K | Sell |
|
|||||
|
2023
Q1 | $269K | Buy |
|
|||||
|
2022
Q4 | $98.1K | Buy |
|
|||||
|
2022
Q3 | $143K | Sell |
|
|||||
|
2022
Q2 | $159K | Sell |
|
|||||
|
2022
Q1 | $222K | Sell |
|
|||||
|
2021
Q4 | $344K | Sell |
|
|||||
|
2021
Q3 | $514K | Sell |
|
|||||
|
2021
Q2 | $802K | Buy |
|
|||||
|
2021
Q1 | $868K | Sell |
|
|||||
|
2020
Q4 | $1.27M | Sell |
|
|||||
|
2020
Q3 | $1.23M | Buy |
|
|||||
|
2020
Q2 | $890K | Buy |
|
|||||
|
2020
Q1 | $73K | Sell |
|
|||||
|
2019
Q4 | $59K | Buy |
|
|||||
|
2019
Q3 | $34K | Sell |
|
|||||
|
2019
Q2 | $120K | Sell |
|
|||||
|
2019
Q1 | $168K | Buy |
|
|||||
|
2018
Q4 | $159K | Sell |
|
|||||
|
2018
Q3 | $522K | Buy |
|
|||||
|
2018
Q2 | $422K | Buy |
|
|||||
|
2018
Q1 | $243K | Sell |
|
|||||
|
2017
Q4 | $221K | Buy |
|
|||||
|
2017
Q3 | $122K | Sell |
|
|||||
|
2017
Q2 | $1.14M | Sell |
|
|||||
|
2017
Q1 | $1.24M | Buy |
|
|||||
|
2016
Q4 | $1.02M | Buy |
|
|||||
|
2016
Q3 | $693K | Sell |
|
|||||
|
2016
Q2 | $634K | Buy |
|
|||||
|
2016
Q1 | $961K | Sell |
|
|||||
|
2015
Q4 | $938K | Sell |
|
|||||
|
2015
Q3 | $1.41M | Buy |
|
|||||
|
2015
Q2 | $2.09M | Buy |
|
|||||
|
2015
Q1 | $4.14M | Buy |
|
|||||
|
2014
Q4 | $2.27M | Sell |
|
|||||
|
2014
Q3 | $1.5M | Buy |
|